Potentiation of penile erection and yawning responses to apomorphine by cannabinoid receptor antagonist in rats

Neuroscience Letters

Volumn 349, Issue 1, 2003, Pages 49-52

  Da Silva, George E ^a   Fernandes, Marcelo S ^a   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Apomorphine; Penile erection; Rats; SR 141716A; Yawning; 9 Tetrahydrocannabinol

Indexed keywords

APOMORPHINE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; DRUG SCREENING; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; TIME; YAWNING;

EID: 0142106897     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00782-1     Document Type: Article

References (15)

1. Argiolas A., Melis M.R. Neuromodulation of penile erection: an overview of the role of neurotransmitters and neuropeptides. Prog. Neurobiol. 47:1995;235-255.
2. Argiolas A., Melis M.R. The neuropharmacology of yawning. Eur. J. Pharmacol. 343:1998;1-16.
3. 2 receptor responses by an anandamide transport inhibitor. J. Neurosci. 20:2000;3401-3407.
4. Carlsson A. Receptor-mediated control of dopamine metabolism. Usdin E., Bunny W.E. Pre- and Postsynaptic Receptors. 1975;49-63 Marcel Dekker, New York.
5. 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci. 41:1987;79-97.
6. 9- tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav. 66:2000;183-187.
7. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2:1999;358-363.
8. Heaton J.P.W. Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci. Biobehav. Rev. 24:2000;561-569.
9. Julian M.D., Martin A.B., Cuellar B., Rodríguez de Fonseca F., Navarro M., Moratalla R., Garcia-Segura L.M. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience. 119:2003;309-318.
10. Nakamura E.M., da Silva E.A., Concílio G.V., Wilkinson D.A., Masur J. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol on memory in the rat. Drug Alcohol Depend. 28:1991;167-175.
11. Nakamura-Palacios E.M., Bueno O.F.A., Takahashi R.N., Tufik S. Acute or chronic effects of cannabinoids on spontaneous or pharmacologically-induced yawning in rats. Pharmacol. Biochem. Behav. 74:2002;205-212.
12. Nasello A.G., Tieppo C.A., Felicio L.F. Apomorphine-induced yawning in the rat: influence of fasting and time of day. Physiol. Behav. 57:1995;967-971.
13. Ottani A., Ferrari F., Giuliani D. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:2002;91-96.
14. Sañudo-Peña M.C., Romero J., Seale G.E., Fernández- Ruiz J.J., Walker J.M. Activational role of cannabinoids on movement. Eur. J. Pharmacol. 391:2000;269-274.
15. Scorticati C., Mohn C., De Laurentiis A., Vissio P., Fernandez Solari J., Seilicovich A., McCann S.M., Rettori V. The effect of anandamide on prolactin secretion is modulated by estrogen. Proc. Natl. Acad. Sci. USA. 100:2003;2134-2139.